New FBI Deputy Director: 3 Facts on the Bongino Role
The new FBI deputy director is beginning their transition. We look at their career, the new role, and the surprising connection to commentator Dan Bongino.
Read More
Epstein’s Connections: 100s of Documents Under GOP Scrutiny
House GOP closes in on Jeffrey Epstein’s connections as his estate is now expected to surrender key documents that could reveal his network of powerful figures.
Trump Seize on New Report: 2 Republicans Demand Answers
As the Biden autopen probe nears its end, Donald Trump seize on a new bombshell Axios report. Rep. Comer joins in, demanding answers and escalating the issue.
IL-17 Drug Phase 3 Success for Junshi’s Psoriasis Med
Junshi Biosciences reports a major phase 3 win for its new il-17 drug targeting psoriasis, signaling a significant advancement and a planned push into the China market.
PD-L1xVEGF Bispecific: 1st Global Data from BioNTech/BMS
BioNTech and BMS reveal promising first-in-human global data for their novel PD-L1xVEGF bispecific antibody, showing potential in treating advanced solid tumors.
London Underground: 7 Days of Strikes Halt Tube Service
Major travel disruption hits the capital as a week-long strike brings the London Underground to a standstill. Find out which lines are affected and the dates.
14 contenders: Ranking the top World Series favorites
We analyze the 14 contenders for the World Series. From top-tier favorites to dark horses, here are the reasons each team can — or can’t — win it all.
Billy Porter: 1 Health Scare Forces Cabaret Broadway Exit
Award-winning star Billy Porter has made the difficult decision to withdraw from his role in Cabaret on Broadway after a serious bout with sepsis. Get the details.
fresh $38m: Motion’s AI Office Suite Gets Big Backing
Y Combinator-backed Motion secures a fresh $38M in funding. The company aims to build the Microsoft Office of AI agents, revolutionizing productivity tools.
Gout Drug from Atom Shows Phase 3 Win Over Rivals
Atom’s new gout drug shows promising Phase 3 trial results, suggesting it could be a superior treatment option and effectively challenge current market leaders.